“Preliminary Aggregate Safety And Immunogenicity Results From Three Trials Of A Purified Inactivated Zika Virus Vaccine Candidate: Phase 1, Randomised, Double-Blind, Placebo-Controlled Clinical Trials.”. Lancet 391 (10120). Lancet: 563-571. doi:10.1016/S0140-6736(17)33106-9.
. 2018. “Safety And Immunogenicity Of A Live Attenuated Tetravalent Dengue Vaccine Candidate In Flavivirus-Naive Adults: A Randomized, Double-Blinded Phase 1 Clinical Trial.”. J Infect Dis 212 (7). J Infect Dis: 1032-41. doi:10.1093/infdis/jiv179.
. 2015. “Higher Antigen Content Improves The Immune Response To 2009 H1N1 Influenza Vaccine In Hiv-Infected Adults: A Randomized Clinical Trial.”. J Infect Dis 205 (5). J Infect Dis: 703-12. doi:10.1093/infdis/jir837.
. 2012.